Category Archives : News

Home  >>  News

Heidelberg, Paris, Prague and Warsaw Build European University Alliance

On March 22, 2018, Posted by , In News, By , , With Comments Off on Heidelberg, Paris, Prague and Warsaw Build European University Alliance

Signing of the declaration on the founding of the European University Alliance “4EU“: From left to right, Prof. Dr Marcin Palys (University of Warsaw), Prof. Dr Jean Chambaz (Sorbonne University), Prof. Dr Bernhard Eitel (Heidelberg University) and Vice-President Prof. Dr Lenka Rovná (on behalf of the President of Charles University…

Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death of advanced squamous lung cancer

On March 21, 2018, Posted by , In News, By , , With Comments Off on Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death of advanced squamous lung cancer

Phase III IMpower131 study showed Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced squamous lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpower131 study met…

HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

On March 21, 2018, Posted by , In News, By , , With Comments Off on HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

HI-STEM, the Heidelberg Institute for Stem Cell Technology and Experimental Medicine at the German Cancer Research Center (DKFZ), is looking back on ten successful years. In numerous types of cancer, HI-STEM researchers have been able to show the role of stem cells in the development, spread and therapy resistance of…

Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

On March 20, 2018, Posted by , In News, By ,, , With Comments Off on Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

Boehringer Ingelheim and Vanderbilt University announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds. The expanded research partnership will focus on the discovery and development of new chemical therapeutics targeting the pro-survival protein MCL1 as a potential therapy against MCL1 dependent cancers. This is the third…

New member: Welcome to PAASP in our cluster

On March 15, 2018, Posted by , In News, By , With Comments Off on New member: Welcome to PAASP in our cluster

We are happy to welcome in our cluster PAASP GmbH (Partnership for Assessment and Accreditation of Scientific Practice). “Quality in Research is the basis for the development of novel drugs.” Anton Bespalov, CEO The PAASP GmbH is a full-service consulting and auditing company that specializes on providing assessment of operational…

Sciomics: Solving Alzheimers with this company’s new approach?

On March 14, 2018, Posted by , In News, By , , With Comments Off on Sciomics: Solving Alzheimers with this company’s new approach?

Labiotech.eu media recently profiled our member Sciomics, a German Cancer Research Center (DKFZ) spin-off founded in 2013 by a team of researchers led by Dr. Christoph Schröder and Dr. Jörg Hoheisel. Sciomics has developed antibody microarrays as a tool for analyzing complex protein samples. Using their expertise, they are able to address…

University of Heidelberg – Innovation Campus: new construction site for the network “Biology at the nanoscale”

On March 13, 2018, Posted by , In News, By , , With Comments Off on University of Heidelberg – Innovation Campus: new construction site for the network “Biology at the nanoscale”

Baden-Württemberg Ministry of Science will support a research bridge between the Ruperto Carola and the Max Planck Institute for Medical Research in Heidelberg, by funding a new building in the life science innovation campus “Heidelberg 4 life”. The funding has been formalized by the Minister of Science, Research and the…

BioMed X and Roche announce research collaboration in the field of immunology

On March 13, 2018, Posted by , In News, By , , With Comments Off on BioMed X and Roche announce research collaboration in the field of immunology

BioMed X announced today the initiation of a new research collaboration with F. Hoffmann-La Roche Ltd in the field of immunology. Within the framework of the agreement, BioMed X will launch a global call for applications to establish a new biomedical research group in Heidelberg. The main objective of the…

New EMBL spinoff company Velabs Therapeutics to accelerate antibody discovery

On March 8, 2018, Posted by , In News, By , , With Comments Off on New EMBL spinoff company Velabs Therapeutics to accelerate antibody discovery

An established proprietary microfluidics technology from the European Molecular Biology Laboratory (EMBL) allows for fast screening of antibodies from natural sources and even difficult targets. With the startup company Velabs Therapeutics, launched by EMBL and its technology transfer arm EMBLEM Technology Transfer GmbH (EMBLEM) together with private investors, the advantages…

EMBL recognises the outstanding work of alumni with the John Kendrew and Lennart Philipson Awards

On March 7, 2018, Posted by , In News, By , , With Comments Off on EMBL recognises the outstanding work of alumni with the John Kendrew and Lennart Philipson Awards

From Big Data to viral enzymes, EMBL alumni are tackling questions across the full range of science disciplines. This year’s alumni awards celebrate this diversity by showcasing the work of Nils Gehlenborg, winner of the 2018 John Kendrew Young Scientist Award, and Raffaele De Francesco, winner of the 2018 Lennart Philipson Award….